View Older Stories View More Recent Stories
-
Valvoline (VVV) Prices 30M Share IPO at $22/Share, at Upper End of Range (ASH)
-
Ashland and Valvoline announce pricing of Valvoline Inc. initial public offering
-
Wood Resources International LLC: The Global Timber Price Index GSPI Was up 4.2% in the 2Q/16 after Having Fallen to the Lowest Level since 2009 in Early 2016
-
Tactile Systems (TCMD) Announces FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment
-
Tactile Medical Receives FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment
-
Fitch Rates BRF GmbH's Proposed Senior Unsecured Notes 'BBB (EXP)'
-
Brazil's inflation eases, bolstering case for rate cut
-
UPDATE: Goldman Sachs Starts Packaging Corp. of America (PKG) at Sell
-
Imprimis Pharma's (IMMY) CEO Publishes Drug Pricing Monograph
-
Following Congressional Hearing Investigating Mylan and Epi-Pen, Imprimis Pharmaceuticals Founder and CEO Publishes Drug Pricing Monograph
-
Daniel Gill Joins Redbridge Debt & Treasury Advisory
-
Avcorp Awarded Multiple Production Contracts from Boeing
-
Jefferies Starts TransDigm (TDG) at Buy
-
Mylan (MYL) September weekly volatility at elevated at 52, CEO testifies before House committee
-
Key Energy Services Announces Commencement of Rights Offering and Solicitation for Votes on its Previously Announced Prepackaged Plan of Reorganization
-
U.S. lawmakers blast Mylan CEO over 'sickening' EpiPen price hikes
-
Deloitte Survey: Oil and Gas Executives See 2017 As a Year of Recovery
-
Netflix (NFLX) Pressured on Market Open, Shares down 3%
-
Caterpillar and Dealers Announce $1 Billion Investment in Business, Education and Training across Africa
-
UPDATE: Oracle Beats Amazon Web Services in Head-to-Head Cloud Database Comparison
-
Fitch: Latin America Non-Food Retail Benefits from Strengthening Credit Profiles
-
Mylan (MYL) September weekly volatility elevated into CEO testifies before House committee
-
Mylan shares languish at low valuation as EpiPen hearing nears
-
Brazil's inflation likely remains near 9 percent in mid-September
-
Senate Republicans seek probe of Mylan EpiPen oversight
-
Market Potential Improves on the Back of Gains in Income, According to First American Chief Economist’s Potential Home Sales Model
-
Altria Group (MO) Announces Expiration of Notes Tender Offer; Sees Q3 Charge
-
Fitch: Municipal Utilities Takes Steps in California to Address Climate Change
-
Altria Announces Expiration of Cash Tender Offer; Reaffirms 2016 Full-Year Earnings Guidance
-
China should apply more differentiated property policy as prices surge: Xinhua
-
HNI Corp. (HNI) Cuts Q3, FY16 Guidance
-
HNI Corporation Updates Earnings Guidance For Third Quarter And Fiscal Year 2016
-
Alliqua BioMedical, Inc. Expands Regenerative Medicine Portfolio with the Commercial Introduction of Interfyl Connective Tissue Matrix
-
RE/MAX (RMAX) Notes 5.8% Increase in Housing Sales for August 2016
-
August Sales Up, Prices Rise Steadily
-
Maslow's Hierarchy Goes Commercial: 30 Universal Elements of Value Can Help Companies Deliver What Customers Really Want
-
Celanese Corporation Announces Pricing of Senior Notes Offering
-
Kline's Index of Base Stock Production and Re-refining Cash Margins Indicates Improved Profitability over the Past Three Months
-
Sonoco-Alcore to Increase Paperboard Prices Across Europe
-
Updated Preliminary Feasibility Study Completed for Seabridge Gold’s KSM Project
-
China big city home prices surge in August adding to worries
-
California governor signs epinephrine bill, blasts Mylan
-
Boralex acquires a portfolio of wind power projects of nearly 200 MW in France and in Scotland
-
Poll shows 66 percent of California voters favor drug price initiative
-
Wolverine Worldwide Announces Completion of Debt Refinancing
-
U.S. congressional panel to hold fuel rules hearing
-
BC Technical Enters Strategic Partnership With Sumitomo Cryogenics
-
Dataram Reports Results for First Quarter Fiscal 2017
-
Drug Stocks on Watch as Bipartisian Bill Expected on Capping Price Increases
-
Kadant Declares Cash Dividend

